Company Zenyatta Ventures Ltd Toronto S.E.
Equities
CA98943A1012
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Nano-graphite and Graphene Materials
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Fenton
CEO | Chief Executive Officer | - | 18-07-10 |
Wendy Ford
DFI | Director of Finance/CFO | - | 22-05-15 |
Adam MacIntosh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 20-02-03 | |
Francis Dubé
COO | Chief Operating Officer | - | 18-05-10 |
Brian Bosse
BRD | Director/Board Member | - | 18-05-10 |
Nick Hansford
PRN | Corporate Officer/Principal | - | 20-12-31 |
Ryan Shacklock
PRN | Corporate Officer/Principal | - | - |
Monique Manaigre
LAW | General Counsel | - | 18-04-30 |
James Jordan
PRN | Corporate Officer/Principal | - | 16-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ilse Treurnicht
BRD | Director/Board Member | - | 22-07-04 |
John Snisarenko
BRD | Director/Board Member | 61 | 23-10-04 |
Francis Dubé
COO | Chief Operating Officer | - | 18-05-10 |
Eric Wallman
CHM | Chairman | - | 18-05-10 |
Brian Bosse
BRD | Director/Board Member | - | 18-05-10 |
Gregory Fenton
CEO | Chief Executive Officer | - | 18-07-10 |
Lisa Sim
BRD | Director/Board Member | - | 23-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 100,819,577 | 94,840,283 ( 94.07 %) | 0 | 94.07 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.49% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |